IBM Watson Health and MedyMatch Technology, a company that uses cognitive analytics for clinical decision support, have joined forces to help clinicians identify intracranial bleeding in head trauma and stroke patients.
MedyMatch's artificial intelligence-powered clinical decision support tool uses deep learning and patient data to help physicians identify the presence of cerebral bleeding. MedyMatch foresees the technology being deployed in hospital emergency rooms and other acute care settings to aid in the treatment of patients suspected of head trauma or stroke.
The first phase of the collaboration involves IBM Watson Health distributing MedyMatch's brain bleed detection application. Eventually, the two companies plan to develop interoperability between the MedyMatch application and IBM Watson Health Imaging's services.